# Omentopexy With Glubran®2 for Reducing Complications After Sleeve Gastrectomy

> **NCT03833232** · PHASE4 · COMPLETED · sponsor: **University of Salerno** · enrollment: 90 (actual)

## Conditions studied

- Obesity With BMI >35

## Interventions

- **DEVICE:** omentopexy with cyanoacrilate glue

## Key facts

- **NCT ID:** NCT03833232
- **Lead sponsor:** University of Salerno
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2017-04-30
- **Final completion:** 2017-05-31
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2019-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03833232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03833232, "Omentopexy With Glubran®2 for Reducing Complications After Sleeve Gastrectomy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03833232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*